Therapeutics News
-
Achieving optimal therapeutic modalities for NCDs in the APMA region
Therapeutics | Opinion | By Hithaishi C Bhaskar | 0 Comment | 16 May, 2024
The Asia Pacific, Middle East and Africa (APMA) region represents almost half of the world's population but healthcare a...Read more
-
Singapore approves J&J's Bispecific Antibody treatment for Multiple Myeloma
Therapeutics | News | 0 Comment | 15 May, 2024
Johnson & Johnson’s first-in-class, bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell-redirectin...Read more
-
Singapore unveils first public-private partnership center for speciality molecular testing
Therapeutics | Company results | By Hithaishi C Bhaskar | 2 Comment | 13 May, 2024
Singapore's National University Hospital (NUH) and leading RNA technology company, Mirxes have officialy unveiled the NU...Read more
-
Singapore suggests repurposing of existing cancer drugs to treat aggressive brain cancer
Therapeutics | News | 0 Comment | 13 May, 2024
Glioblastoma is an often fatal form of brain cancer, with only five per cent of patients surviving beyond five years. Th...Read more
-
New biotech research and manufacturing hub opens at University of Queensland, Australia
Therapeutics | News | 0 Comment | 10 May, 2024
A range of hyper accurate cancer drugs is in production at a newly opened research and manufacturing hub at The Universi...Read more
-
RBobay Pharma boosts CRDMO offerings with Cytiva's FlexFactory platform
Therapeutics | News | 0 Comment | 09 May, 2024
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDM...Read more
-
Navigation and evaluation of the 'Long COVID' impact on Asia's public health
Therapeutics | Opinion | 0 Comment | 08 May, 2024
The SARS CoV-2 infection can cause a wide range of recurring or persistent health concerns among the populations infecte...Read more
-
Therapeutics | News | 0 Comment | 08 May, 2024
A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and Bioinformatics Institute (BII) has deve...Read more
-
GIBF invests $10 M in Israel-based startup Nectin Therapeutics to advance Antibody Drug Conjugates
Therapeutics | News | 0 Comment | 06 May, 2024
Guangzhou-Israel Biotechnology Fund (GIBF) has invested $10 million in Nectin Therapeutics. Israel-b...Read more
-
An integrated approach to combat canine rabies in Southeast Asia
Therapeutics | Opinion | By Hithaishi C Bhaksar | 0 Comment | 06 May, 2024
Rabies is a neglected zoonotic disease caused by RNA virus from Rhabdoviridae family, potentially fatal if not treated. ...Read more
-
Singapore unveils ways for novel therapeutic interventions in Alzheimer’s disease
Therapeutics | News | 0 Comment | 06 May, 2024
In a groundbreaking study published in Cell Research, researchers from the Yong Loo Lin School of Medicine at the Nation...Read more
-
Nanotech opens door to future of insulin medication in Australia
Therapeutics | News | 0 Comment | 03 May, 2024
Research led by the University of Sydney and Sydney Local Health District has developed a new type of oral insulin bas...Read more
-
Ora and Singapore Eye Research Institute to propel ophthalmology innovation globally
Therapeutics | News | 0 Comment | 03 May, 2024
Ora, Inc., a US-based ophthalmology contract research organisation (CRO), has announced a strategic, exclusive partnersh...Read more
-
“We are exploring opportunities to collaborate with startups and incubators”
Therapeutics | Opinion | By Hithaishi C Bhaskar | 0 Comment | 01 May, 2024
How is Agilent advancing cell and gene therapy modalities to enable next-gen therapeutics and applications? What are A...Read more
-
Therapeutics | News | 0 Comment | 25 Apr, 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore fa...Read more
-
Australia invests $152.4 M to nationally boost melanoma care and research
Therapeutics | News | 0 Comment | 24 Apr, 2024
The Paula Fox Melanoma and Cancer Centre, a partnership between Monash University, The Alfred and Minderoo Foundation, i...Read more
-
Hong Kong develops machine learning model to predict risk of severe hypoglycemia in diabetics
Therapeutics | News | 0 Comment | 23 Apr, 2024
In Hong Kong, one in three adults over the age of 65 have diabetes. To improve the management of this group of older adu...Read more
-
Korean firms OSR Holdings and SillaJen ink deal to develop innovative therapies and enter US market
Therapeutics | News | 0 Comment | 23 Apr, 2024
South Korea-based biotech startup OSR Holdings has signed a Memorandum of Understanding (MoU) with SillaJen, a Kosdaq-li...Read more
